Skip to main content

Advertisement

SpringerLink
Log in

The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)

  • Consensus Statement
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ART:

Assisted reproductive technologies

FSH:

Follicle stimulating hormone

FSHR:

FSH receptor

GnRH-a:

Gonadotropin-releasing hormone agonist

hCG:

Human chorionic gonadotropin

hMG:

Human menopausal gonadotropin

hpFSH:

Highly purified follicle stimulating hormone

ICSI:

Intracytoplasmic sperm injection

IUI:

Intrauterine insemination

IVF:

In vitro fertilization

IVF-ET:

In vitro fertilization-embryo transfer

OAT:

Oligo/astheno/teratozoospermia

pFSH:

Purified follicle stimulating hormone

RCT:

Randomized controlled trial

rhFSH:

Recombinant human follicle stimulating hormone

References

  1. Isaksson R, Tiitinen A (2004) Present concept of unexplained infertility. Gynecol Endocrinol 18(5):278–290

    Article  PubMed  CAS  Google Scholar 

  2. Krausz C (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25(2):271–285

    Article  PubMed  Google Scholar 

  3. Tournaye H, Krausz C, Oates RD (2017) Novel concepts in the aetiology of male reproductive impairment. Lancet Diabetes Endocrinol 5(7):544–553

    Article  PubMed  Google Scholar 

  4. Wang SX (2011) The past, present, and future of embryo selection in in vitro fertilization: frontiers in reproduction conference. Yale J Biol Med 84(4):487–490

    PubMed  PubMed Central  Google Scholar 

  5. Singh K, Jaiswal D (2011) Human male infertility: a complex multifactorial phenotype. Reprod Sci 18(5):418–425

    Article  PubMed  Google Scholar 

  6. Hirsh A (2003) Male subfertility. BMJ 327(7416):669–672

    Article  PubMed  PubMed Central  Google Scholar 

  7. Baccetti B, Strehler E, Capitani S, Collodel G, De Santo M, Moretti E et al (1997) The effect of follicle-stimulating hormone therapy on human sperm structure (Notulae seminologicae). Hum Reprod 12(9):1955–1968

    Article  PubMed  CAS  Google Scholar 

  8. Kliesch S, Behre HM, Nieschlag E (1995) Recombinant human follicle stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadal male. Fertil Steril 63(6):1326–1328

    Article  PubMed  CAS  Google Scholar 

  9. van Rijkom J, Leufkens H, Crommelin D, Rutten F, Broekmans A (1999) Assessment of biotechnology drugs: what are the issues? Health Policy 47(3):255–274

    Article  PubMed  Google Scholar 

  10. Zwart-van Rijkom JE, Broekmans FJ, Leufkens HG (2002) From HMG through purified urinary FSH preparations to recombinant FSH: a substitution study. Hum Reprod 17(4):857–865

    Article  PubMed  CAS  Google Scholar 

  11. Vicari E, Mongioì A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D’Agata R (1992) Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism-long-term follow-up. Int J Androl 15(4):320–329

    Article  PubMed  CAS  Google Scholar 

  12. Zacharin M, Sabin MA, Nair VV, Dabadghao P (2012) Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril 98(4):836–842

    Article  PubMed  CAS  Google Scholar 

  13. La Vignera S, Condorelli RA, Cimino L, Russo GI, Morgia G, Calogero AE (2016) Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone. Aging Male 19(1):34–39

    Article  PubMed  Google Scholar 

  14. Acosta AA, Oehninger S, Ertunc H, Philput C (1991) Possible role of pure human follicle-stimulating hormone in the treatment of severe male infertility by assisted reproduction: preliminary report. Fertil Steril 55(6):1150–1156

    Article  PubMed  CAS  Google Scholar 

  15. Acosta AA, Khalifa E, Oehninger S (1992) Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk’s total experience. Hum Reprod 7(8):1067–1072

    Article  PubMed  CAS  Google Scholar 

  16. Bartoov B, Eltes F, Lunenfeld E, Har-Even D, Lederman H, Lunenfeld B (1994) Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 61(4):727–734

    Article  PubMed  CAS  Google Scholar 

  17. Matorras R, Perez C, Corcostegui B, Pijoan JI, Ramon O, Delgado P et al (1997) Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband’s spermatozoa: a randomized study. Hum Reprod 12(1):24–28

    Article  PubMed  CAS  Google Scholar 

  18. Kamischke A, Behre HM, Bergmann M, Simoni M, Schäfer T, Nieschlag E (1998) Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13(3):596–603

    Article  PubMed  CAS  Google Scholar 

  19. Ben-Rafael Z, Farhi J, Feldberg D, Bartoov B, Kovo M, Eltes F et al (2000) Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 73(1):24–30

    Article  PubMed  CAS  Google Scholar 

  20. Baccetti B, Piomboni P, Bruni E, Capitani S, Gambera L, Moretti E et al (2004) Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian J Androl 6(2):133–137

    PubMed  CAS  Google Scholar 

  21. Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A (2005) Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 84(3):654–661

    Article  PubMed  CAS  Google Scholar 

  22. Efesoy O, Cayan S, Akbay E (2009) The efficacy of recombinant human follicle-stimulating hormone in the treatment of various types of male-factor infertility at a single university hospital. J Androl 30(6):679–684

    Article  PubMed  CAS  Google Scholar 

  23. Colacurci N, Monti MG, Fornaro F, Izzo G, Izzo P, Trotta C et al (2012) Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. J Androl 33(4):588–593

    Article  PubMed  CAS  Google Scholar 

  24. Ding YM, Zhang XJ, Li JP, Chen SS, Zhang RT, Tan WL et al (2015) Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population. Clin Endocrinol (Oxf) 83(6):866–871

    Article  CAS  Google Scholar 

  25. Sigg C, Baclu M (1994) Improvement of sperm concentration and bovine mucus penetration in idiopathic oligozoospermia by administration of pure FSH. Hum Reprod 9(Suppl 4):47

    Article  Google Scholar 

  26. Merino G, Carranza-Lira S, Martinez-Chequer JC (1996) Sperm characteristics and hormonal profile before and after treatment with follicle-stimulating hormone in infertile patients. Arch Androl 37(3):197–200

    Article  PubMed  CAS  Google Scholar 

  27. Strehler E, Sterzik K, De Santo M, Abt M, Wiedemann R, Bellati U et al (1997) The effect of follicle-stimulating hormone therapy on sperm quality: an ultrastructural mathematical evaluation. J Androl 18(4):439–447

    PubMed  CAS  Google Scholar 

  28. Glander HJ, Kratzsch J (1997) Effects of pure human follicle stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotropin-releasing hormone (GnRH). Andrologia 29(1):23–28

    Article  PubMed  CAS  Google Scholar 

  29. Radicioni A, Schwarzenberg TL (1999) The use of FSH in adolescents and young adults with idiopathic, unilateral, left varicocele not undergoing surgical intervention. Preliminary study. Minerva Endocrinol 24(2):63–68

    PubMed  CAS  Google Scholar 

  30. Arnaldi G, Balercia G, Barbatelli G, Mantero F (2000) Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia. Andrologia 32(3):155–161

    Article  PubMed  CAS  Google Scholar 

  31. Foresta C, Bettella A, Merico M, Garolla A, Plebani M, Ferlin A et al (2000) FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 161(1–2):89–97

    Article  PubMed  CAS  Google Scholar 

  32. Zarrilli S, Paesano L, Colao A, Mirone V, Lombardi G, De Rosa M (2000) FSH treatment improves sperm function in patients after varicocelectomy. J Endocrinol Invest 23(2):68–73

    Article  PubMed  CAS  Google Scholar 

  33. Caroppo E, Niederberger C, Vizziello GM, D’Amato G (2003) Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril 80(6):1398–1403

    Article  PubMed  Google Scholar 

  34. Fernández-Arjona M, Díaz J, Cortes I, González J, Rodriguez JM, Alvarez E (2003) Relationship between gonadotrophin secretion, inhibin B and spermatogenesis in oligozoospermic men treated with highly purified urinary follicle-stimulating hormone (uFSH-HP): a preliminary report. Eur J Obstet Gynecol Reprod Biol 107(1):47–51

    Article  PubMed  Google Scholar 

  35. Paradisi R, Busacchi P, Seracchioli R, Porcu E, Venturoli S (2006) Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. Fertil Steril 86(3):728–731

    Article  PubMed  CAS  Google Scholar 

  36. Valenti D, La Vignera S, Condorelli RA, Rago R, Barone N, Vicari E et al (2013) Follicle-stimulating hormone treatment in normogonadotropic infertile men. Nat Rev Urol 10(1):55–62

    Article  PubMed  CAS  Google Scholar 

  37. Condorelli RA, Calogero AE, Vicari E, Mongioi’ L, Burgio G, Cannarella R et al (2014) Reduced seminal concentration of CD45pos cells after follicle-stimulating hormone treatment in selected patients with idiopathic oligoasthenoteratozoospermia. Int J Endocrinol 2014:372060

    PubMed  PubMed Central  Google Scholar 

  38. Paradisi R, Natali F, Fabbri R, Battaglia C, Seracchioli R, Venturoli S (2014) Evidence for a stimulatory role of high doses of recombinant human follicle-stimulating hormone in the treatment of male-factor infertility. Andrologia 46(9):1067–1072

    Article  PubMed  CAS  Google Scholar 

  39. Farrag A, Sagnella F, Pappalardo S, Costantini A, Lisi F, Carfagna P et al (2015) The use of r-hFSH in treatment of idiopathic male factor infertility before ICSI. Eur Rev Med Pharmacol Sci 19(12):2162–2167

    PubMed  CAS  Google Scholar 

  40. Casamonti E, Vinci S, Serra E, Fino MG, Brilli S, Lotti F et al (2017) Short-term FSH treatment and sperm maturation: a prospective study in idiopathic infertile men. Andrology 5(3):414–422

    Article  PubMed  CAS  Google Scholar 

  41. Garolla A, Ghezzi M, Cosci I, Sartini B, Bottacin A, Engl B et al (2017) FSH treatment in infertile males candidate to assisted reproduction improved sperm DNA fragmentation and pregnancy rate. Endocrine 56(2):416–425

    Article  PubMed  CAS  Google Scholar 

  42. Attia AM, Abou-Setta AM, Al-Inany HG (2013) Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 23(8):CD005071

    Google Scholar 

  43. Santi D, Granata AR, Simoni M (2015) FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect 4(3):R46–R58

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Swiglo BA, Murad MH, Schünemann HJ, Kunz R, Vigersky RA, Guyatt GH et al (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93(3):666–673

    Article  PubMed  CAS  Google Scholar 

  45. Palomba S, Falbo A, Espinola S, Rocca M, Capasso S, Cappiello F et al (2011) Effects of highly purified follicle-stimulating hormone on sperm DNA damage in men with male idiopathic subfertility: a pilot study. J Endocrinol Invest 34(10):747–752

    PubMed  CAS  Google Scholar 

  46. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A, Rossato M (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77(2):238–244

    Article  PubMed  Google Scholar 

  47. Knuth UA, Honigl W, Bals-Pratsch M, Schleicher G, Nieschlag E (1987) Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab 65(6):1081–1087

    Article  PubMed  CAS  Google Scholar 

  48. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A, Foresta C (2011) The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl 34(4):306–312

    Article  PubMed  CAS  Google Scholar 

  49. Ashkenazi J, Bar-Hava I, Farhi J, Levy T, Feldberg D, Orvieto R et al (1999) The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril 72(4):670–673

    Article  PubMed  CAS  Google Scholar 

  50. Foresta C, Selice R, Moretti A, Pati MA, Carraro M, Engl B et al (2009) Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies. Fertil Steril 92(4):1326–1332

    Article  PubMed  CAS  Google Scholar 

  51. Zini A (2011) Are sperm chromatin and DNA defects relevant in the clinic? Syst Biol Reprod Med 57(1–2):78–85

    Article  PubMed  Google Scholar 

  52. Smit M, van Casteren NJ, Wildhagen MF, Romijn JC, Dohle GR (2010) Sperm DNA integrity in cancer patients before and after cytotoxic treatment. Hum Reprod 25(8):1877–1883

    Article  PubMed  CAS  Google Scholar 

  53. Ribas-Maynou J, Gawecka JE, Benet J, Ward WS (2014) Double-stranded DNA breaks hidden in the neutral Comet assay suggest a role of the sperm nuclear matrix in DNA integrity maintenance. Mol Hum Reprod 20(4):330–340

    Article  PubMed  CAS  Google Scholar 

  54. Muratori M, Tamburrino L, Marchiani S, Cambi M, Olivito B, Azzari C et al (2015) Investigation on the origin of sperm DNA Fragmentation: role of apoptosis, immaturity and oxidative stress. Mol Med 21:109–122

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Zini A, Bielecki R, Phang D, Zenzes MT (2001) Correlations between two markers of sperm DNA integrity, DNA denaturation and DNA fragmentation, in fertile and infertile men. Fertil Steril 75(4):674–677

    Article  PubMed  CAS  Google Scholar 

  56. Zini A, Boman JM, Belzile E, Ciampi A (2008) Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Hum Reprod 23(12):2663–2668

    Article  PubMed  CAS  Google Scholar 

  57. Carrell DT, Wilcox AL, Lowy L, Peterson CM, Jones KP, Erickson L et al (2003) Elevated sperm chromosome aneuploidy and apoptosis in patients with unexplained recurrent pregnancy loss. Obstet Gynecol 101(6):1229–1235

    PubMed  Google Scholar 

  58. Carlini T, Paoli D, Pelloni M, Faja F, Dal Lago A, Lombardo F et al (2017) Sperm DNA fragmentation in Italian couples with recurrent pregnancy loss. Reprod Biomed Online 34(1):58–65

    Article  PubMed  Google Scholar 

  59. Robinson L, Gallos ID, Conner SJ, Rajkhowa M, Miller D, Lewis S et al (2012) The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum Reprod 27(10):2908–2917

    Article  PubMed  CAS  Google Scholar 

  60. Muratori M, Forti G, Baldi E (2008) Comparing flow cytometry and fluorescence microscopy for analyzing human sperm DNA fragmentation by TUNEL labeling. Cytom A 73(9):785–787

    Article  Google Scholar 

  61. Evenson DP, Wixon R (2006) Clinical aspects of sperm DNA fragmentation detection and male infertility. Theriogenology 65(5):979–991

    Article  PubMed  CAS  Google Scholar 

  62. Castillo J, Estanyol JM, Ballesca JL, Oliva R (2015) Human sperm chromatin epigenetic potential: genomics, proteomics, and male infertility. Asian J Androl 17(4):601–609

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Simon L, Zini A, Dyachenko A, Ciampi A, Carrell DT (2017) A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome. Asian J Androl 19(1):80–90

    PubMed  Google Scholar 

  64. Ruvolo G, Roccheri MC, Brucculeri AM, Longobardi S, Cittadini E, Bosco L (2013) Lower sperm DNA fragmentation after r-FSH administration in functional hypogonadotropic hypogonadism. J Assist Reprod Genet 30(4):497–503

    Article  PubMed  PubMed Central  Google Scholar 

  65. Simoni M, Santi D, Negri L, Hoffmann I, Muratori M, Baldi E et al (2016) Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p. N680S: a pharmacogenetic study. Hum Reprod 31(9):1960–1969

    Article  PubMed  Google Scholar 

  66. Piomboni P, Serafini F, Gambera L, Musacchio C, Collodel G, Morgante G et al (2009) Sperm aneuploidies after human recombinant follicle stimulating hormone therapy in infertile males. Reprod Biomed Online 18(5):622–629

    Article  PubMed  Google Scholar 

  67. Attia AM, Al-Inany HG, Farquhar C, Proctor M (2007) Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 17:CD005071

    Google Scholar 

  68. Foresta C, Bettella A, Ferlin A, Garolla A, Rossato M (1998) Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil Steril 69(4):636–642

    Article  PubMed  CAS  Google Scholar 

  69. Garolla A, Selice R, Engl B, Bertoldo A, Menegazzo M, Finos L et al (2014) Spermatid count as a predictor of response to FSH therapy. Reprod Biomed Online 29(1):102–112

    Article  PubMed  CAS  Google Scholar 

  70. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J et al (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82(6):959–968

    Article  PubMed  CAS  Google Scholar 

  71. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P et al (2005) Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenetics Genomics 15(7):451–456

    Article  PubMed  CAS  Google Scholar 

  72. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L et al (2005) A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90(8):4866–4872

    Article  PubMed  CAS  Google Scholar 

  73. Tuttelmann F, Laan M, Grigorova M, Punab M, Sober S, Gromoll J (2012) Combined effects of the variants FSHB-211G > T and FSHR 2039A > G on male reproductive parameters. J Clin Endocrinol Metab 97(10):3639–3647

    Article  PubMed  Google Scholar 

  74. Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology and pathophysiology. Endocr Rev 18(6):739–773

    PubMed  CAS  Google Scholar 

  75. Liu JY, Gromoll J, Cedars MI, La Barbera AR (1998) Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea. Fertil Steril 70(2):326–331

    Article  PubMed  CAS  Google Scholar 

  76. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D et al (1999) Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84(2):751–755

    PubMed  CAS  Google Scholar 

  77. Grigorova M, Rull K, Laan M (2007) Haplotype structure of FSHB, the beta-subunit gene for fertility-associated follicle-stimulating hormone: possible influence of balancing selection. Ann Hum Genet 71(Pt 1):18–28

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Grigorova M, Punab M, Ausmees K, Laan M (2008) FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 23(9):2160–2166

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  79. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC, Foresta C (2011) Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril 96(6):1344–1349

    Article  PubMed  CAS  Google Scholar 

  80. Worrilow KC, Eid S, Woodhouse D, Perloe M, Smith S, Witmyer J et al (2013) Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes-multicenter, double-blinded and randomized controlledtrial. Hum Reprod 28(2):306–314

    Article  PubMed  CAS  Google Scholar 

  81. Grigorova M, Punab M, Punab AM, Poolamets O, Vihljajev V, Zilaitienė B et al (2014) Reproductive physiology in young men is cumulatively affected by FSH-action modulating genetic variants: FSHR -29G/A and c.2039 A/G, FSHB -211G/T. PLoS ONE 9(4):e94244

    Article  PubMed  PubMed Central  Google Scholar 

  82. Iacono F, Barra S, Montano L, Lotti T (1996) Value of high-dose pure FSH in the treatment of idiopathic male infertility. J Urol (Paris) 102(2):81–84

    CAS  Google Scholar 

  83. Dirnfeld M, Katz G, Calderon I, Abramovici H, Bider D (2000) Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in vitro fertilization is beneficial. Eur J Obstet Gynecol Reprod Biol 93(1):105–108

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

No specific funding was used in relation to this manuscript

Author information

Author notes

  1. A. Ferlin

    Present address: Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

Authors and Affiliations

  1. Casa di Cura San Raffaele Sulmona, Sulmona, AQ, Italy

    A. Barbonetti

  2. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy

    A. E. Calogero & S. La Vignera

  3. Division of Endocrinology, Department of Clinical and Molecular Sciences, Umberto I Hospital, Ancona, Polytechnic University of Marche, Ancona, Italy

    G. Balercia

  4. Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padua, Italy

    A. Garolla, C. Foresta & A. Ferlin

  5. Department of Biomedical, Experimental and Clinical Sciences ‘Mario Serio’, University of Florence, Florence, Italy

    C. Krausz & M. Maggi

  6. Laboratory of Seminology-Sperm Bank “Loredana Gandini”, Department of Experimental Medicine, University of Rome “La Sapienza”, Rome, Italy

    F. Lombardo & A. Lenzi

  7. Department of Systems Medicine, Chair of Endocrinology and Medical Sexology (ENDOSEX), University of Rome Tor Vergata, Rome, Italy

    E. A. Jannini

Authors
  1. A. Barbonetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. E. Calogero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Balercia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Garolla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Krausz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. La Vignera
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Lombardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. A. Jannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Maggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. Lenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. C. Foresta
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. Ferlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Ferlin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Does not apply to this kind of paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barbonetti, A., Calogero, A.E., Balercia, G. et al. The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS). J Endocrinol Invest 41, 1107–1122 (2018). https://doi.org/10.1007/s40618-018-0843-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-018-0843-y

Keywords

Search

Navigation